Evidence map›Paper›PMID 35898465›Full record

ArticleFrontiers in endocrinology2022

Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study.

Zhaonan Wang, Jonathan Hazlehurst, Anuradhaa Subramanian, Abd A Tahrani, Wasim Hanif, Neil Thomas, Pushpa Singh, Jingya Wang, Christopher Sainsbury, Krishnarajah Nirantharakumar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zhaonan WangInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Jonathan HazlehurstInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Anuradhaa SubramanianInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Abd A TahraniDepartment of Diabetes and Endocrinology, University Hospital Birmingham Foundation Trust, Birmingham, United Kingdom.
Wasim HanifDepartment of Diabetes and Endocrinology, University Hospital Birmingham Foundation Trust, Birmingham, United Kingdom.
Neil ThomasInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Pushpa SinghDepartment of Diabetes and Endocrinology, University Hospital Birmingham Foundation Trust, Birmingham, United Kingdom.
Jingya WangInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Christopher SainsburyInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Krishnarajah NirantharakumarInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Francesca L CroweInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
University of Birmingham · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBGartnavel General Hospital · GBHealth Data Research UK · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: We aimed to compare the mortality of individuals at low, moderate, and high risk of diabetic foot disease (DFD) in the context of newly diagnosed type 2 diabetes, before developing active diabetic foot problem. Methods: This was a population-based cohort study of adults with newly diagnosed type 2 diabetes utilizing IQVIA Medical Research Data. The outcome was all-cause mortality among individuals with low, moderate, and high risk of DFD, and also in those with no record of foot assessment and those who declined foot examination. Results: Of 225,787 individuals with newly diagnosed type 2 diabetes, 34,061 (15.1%) died during the study period from January 1, 2000 to December 31, 2019. Moderate risk and high risk of DFD were associated with increased mortality risk compared to low risk of DFD (adjusted hazard ratio [aHR] 1.50, 95% CI 1.42, 1.58; aHR 2.01, 95% CI 1.84, 2.20, respectively). Individuals who declined foot examination or who had no record also had increased mortality risk of 75% and 25% vs. those at low risk of DFD, respectively (aHR 1.75, 95% CI 1.51, 2.04; aHR 1.25, 95% CI 1.20, 1.30). Conclusion: Individuals with new-onset type 2 diabetes who had moderate to high risk of DFD were more likely to die compared to those at low risk of DFD. The associations between declined foot examination and absence of foot examinations, and increased risk of mortality further highlight the importance of assessing foot risk as it identifies not only patients at risk of diabetic foot ulceration but also mortality.

Indexed as

Diabetes Mellitus, Type 2Diabetic FootAdultCohort StudiesFootHumansProportional Hazards ModelsRisk Assessmentdiabetic foot diseasediabetic foot riskfoot risk examinationmortalitytype 2 diabetes

Identifiers

PMID35898465
PMCPMC9309507
OpenAlexW4285012638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.